American Society for Clinical Pathology

Targeted Treatment for Advanced Breast Cancer Including CDK4/6 Inhibitor Therapy Reaches Patients in Mozambique for the First Time

Retrieved on: 
Thursday, November 9, 2023
Knowledge, Cepheid variable, Partner, Survival, Pathology, PACT, American Society for Clinical Pathology, Breast cancer, Access, Society, Death, Quality of life, ABC, Saint Lucia, Health equity, Novartis, Palliative care, Woman, Oncology, Breast cancer awareness, Cancer, Patient, Diagnosis, HR, Pharmaceutical industry, Medical device, Medical imaging, Humanitarianism, Developing country

"This is an important day for women living with advanced breast cancer in Mozambique and beyond.

Key Points: 
  • "This is an important day for women living with advanced breast cancer in Mozambique and beyond.
  • For the first time they will be able to access the latest treatment at no cost," said Pat Garcia-Gonzalez, CEO of The Max Foundation.
  • "Access to adequate diagnosis and treatment is paramount to change the survival and the quality of life of patients with advanced breast cancer.
  • Breast cancer is usually diagnosed at late stages, and due to limited resources, patients may receive inadequate treatment, including supportive and palliative care.

American Society for Clinical Pathology Awarded $631,983 Grant from the CDC to Strengthen the Laboratory Workforce

Retrieved on: 
Tuesday, September 26, 2023
Workforce, Learning, Medicine, Society, Joint Commission, Education, Building Bridges, Culture, Public, Marie Cassidy, American Society for Clinical Pathology, Pathology, Research, Strategic planning, Doctor of Philosophy, ASCP, CDC, Health, Global Health, MD, Laboratory, Master of Science, Korea Disease Control and Prevention Agency, SCT, Knowledge, Negotiation, Principal, USPS Building Bridges Special Postal Cancellation Series, Environment, News, Finance, Pharmaceutical industry, Nursing, Growth

CHICAGO, Sept. 26, 2023 /PRNewswire-PRWeb/ -- The American Society for Clinical Pathology (ASCP) has been awarded an additional $631,893 grant as part of a three-year grant from the Centers for Disease Control and Prevention (CDC) to strengthen the laboratory workforce in the United States. This multi-year grant, which began in September 2022, has allowed ASCP to respond to public health emergencies and foster the development of a quality- and patient-centric community of practice.

Key Points: 
  • CHICAGO, Sept. 26, 2023 /PRNewswire-PRWeb/ -- The American Society for Clinical Pathology (ASCP) has been awarded an additional $631,893 grant as part of a three-year grant from the Centers for Disease Control and Prevention (CDC) to strengthen the laboratory workforce in the United States.
  • ASCP CEO Blair Holladay, PhD, MASCP, SCT(ASCP)CM
    The Society has worked closely with the CDC to connect ASCP's universe of more than 250,000 pathologists and laboratory professionals to the CDC OneLab Network.
  • ASCP's involvement in the OneLab initiative is part of the Society's comprehensive strategies to address the medical laboratory workforce shortage."
  • Moving into the second year of this three-year grant, ASCP's efforts remain centered around strengthening the laboratory workforce, and maintaining our role as the go-to resource for laboratory advocacy.

New Members Named to the ABMS Board of Directors

Retrieved on: 
Tuesday, July 11, 2023
American Board of Medical Specialties, American Society for Clinical Laboratory Science, ABMS, American Board of Pathology, Professional, Certification, American Medical Association, Medical specialty, American Board of Commissioners for Foreign Missions, Physician, Patient, Executive Committee, American Society for Clinical Pathology, Accreditation, Knowledge, Accreditation Council, Chair, Management, MD, Pathology

CHICAGO, July 11, 2023 /PRNewswire/ -- The American Board of Medical Specialties (ABMS), the leading not-for-profit organization overseeing certification of physicians and medical specialists in the United States, is pleased to announce the election of Rebecca L. Johnson, MD, former Chief Executive Officer of the American Board of Pathology, as the new Chair of the ABMS Board of Directors. In addition, three new members were also elected to serve on Board of Directors at the ABMS Board meeting held in late June.

Key Points: 
  • CHICAGO, July 11, 2023 /PRNewswire/ -- The American Board of Medical Specialties (ABMS), the leading not-for-profit organization overseeing certification of physicians and medical specialists in the United States, is pleased to announce the election of Rebecca L. Johnson, MD, former Chief Executive Officer of the American Board of Pathology, as the new Chair of the ABMS Board of Directors .
  • In addition, three new members were also elected to serve on Board of Directors at the ABMS Board meeting held in late June.
  • "For 90 years, ABMS has relied upon the knowledge and experience of dedicated volunteer leaders to ensure that ABMS board certification represents a high standard for professional self-regulation," stated Richard E. Hawkins, MD, ABMS President and Chief Executive Officer.
  • "We welcome our three newest Board Members and look forward to working with them and Dr. Johnson in advancing the importance of board certification for the profession and the patients and communities we serve."

The Max Foundation to Launch Treatment Access for Advanced Breast Cancer in Nine Countries Across Africa, Latin America, and South Asia in Q3 2023

Retrieved on: 
Thursday, June 1, 2023
Partnership, American Society for Clinical Pathology, Breast cancer awareness, Partner, Breast cancer, Survival, Health equity, Cancer, Quality of life, Max, Woman, Pathology, PACT, Death, Novartis, Patient, Developed country, Physician, Access, ABC, Cepheid variable, Humble Quest, Palliative care, Diagnosis, Knowledge, Oncology, Society, Pharmaceutical industry, Nursing, Medical imaging, Birth control, Developing country, Humanitarianism

Max is working in collaboration with multiple partners to implement the program through its Humanitarian Partnership for Access to Cancer Treatment (Humanitarian PACT) for Advanced Breast Cancer.

Key Points: 
  • Max is working in collaboration with multiple partners to implement the program through its Humanitarian Partnership for Access to Cancer Treatment (Humanitarian PACT) for Advanced Breast Cancer.
  • Partners in the Humanitarian PACT for Advanced Breast Cancer have agreed to invest resources and/or their unique knowledge and capabilities to support the expansion of Max Access Solutions to provide access to treatment for HR+/HER2- advanced breast cancer.
  • Close to than 45,000 people have received access to treatment through Max Access Solutions, which now operates in over 70 low-resource countries.
  • Breast cancer is the most common cancer in women with 25% of all cancers diagnosed in women being breast cancer.

Dr. David Heydt Named Medical Director of Capital Digestive Care Laboratory

Retrieved on: 
Wednesday, March 1, 2023
New York Medical College, Memorial Sloan Kettering Cancer Center, American Medical Association, College of American Pathologists, College, Capital, American Society for Clinical Pathology, West Jefferson Medical Center, Heydt, American Board of Commissioners for Foreign Missions, Spring, Society, MD, Pathology

Silver Spring, MD, March 01, 2023 (GLOBE NEWSWIRE) -- Capital Digestive Care has announced that David Heydt has been named medical director of Capital Digestive Care Laboratory effective March 1, 2023.

Key Points: 
  • Silver Spring, MD, March 01, 2023 (GLOBE NEWSWIRE) -- Capital Digestive Care has announced that David Heydt has been named medical director of Capital Digestive Care Laboratory effective March 1, 2023.
  • In his new role, Dr. Heydt will provide clinical oversight of the laboratory as well as clinician and staff education while assisting with innovative laboratory projects and partnerships.
  • Dr. Heydt had previously served as the laboratory’s acting anatomic pathology director for the last three years.
  • Prior to joining Capital Digestive Care, he was a staff pathologist at Miraca Life Sciences in Union, New Jersey.

Lester J. Layfield, MD, FASCP is recognized by Continental Who's Who

Retrieved on: 
Monday, February 13, 2023
Physician, International Academy, Mentorship, David Geffen School of Medicine at UCLA, Continental, Diagnosis, World Health Organization, Tissue, Head, University of Missouri School of Medicine, University, American Society of Cytopathology, ARUP, Patient, Lung, Malignancy, American Board of Pathology, Neck, Research, ASCP, Risk, Chester L. Krause Memorial Distinguished Service Award, University of Washington Medical Center, Pathology, University of Missouri School of Health Professions, Marie Cassidy, Student, American Society for Clinical Pathology, American Board of Commissioners for Foreign Missions, Lung cancer, Disease, Pancreas, Breast, ABP, Surgical pathology, Society, UCLA, Teaching hospital, Dentistry, Nursing, MD

COLUMBIA, Miss., Feb. 13, 2023 /PRNewswire/ -- Lester J. Layfield, MD, FASCP, is being recognized by Continental Who's Who as a Distinguished Healthcare Provider for his work as a Pathologist.

Key Points: 
  • COLUMBIA, Miss., Feb. 13, 2023 /PRNewswire/ -- Lester J. Layfield, MD, FASCP, is being recognized by Continental Who's Who as a Distinguished Healthcare Provider for his work as a Pathologist.
  • He completed an internship in pathology, anatomic pathology, and clinical pathology at the University of Washington Medical Center.
  • He completed his residency in pathology, anatomic pathology, and clinical pathology at the University of California in San Diego.
  • Dr. Layfield is considered an expert in cytopathology with fine needle aspirations, and surgical pathology involving head, neck and musculoskeletal pathology.

Accumen leader, Stephen Bishop, Named Certified Professional in Healthcare Quality by the NAHQ

Retrieved on: 
Tuesday, January 17, 2023
Certified Professional in Supply Management, Certification, Leadership studies, ASCP, Hospital, Patient safety, University, Health, Public health, Vocabulary, Safety, Bishop, Accreditation, Organization, National Association, Population health, MLS, California Department of Public Health, California Department, Society, American Society for Clinical Pathology, MBA, Master of Science in Organizational Leadership, Medicine, Science

Scottsdale, AZ, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Stephen Bishop, MBA, MS, MLS (ASCP), CPHQ, a healthcare consultant at Accumen Inc., was named Certified Professional in Healthcare Quality by the National Association for Healthcare Quality (NAHQ).

Key Points: 
  • Scottsdale, AZ, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Stephen Bishop, MBA, MS, MLS (ASCP), CPHQ, a healthcare consultant at Accumen Inc., was named Certified Professional in Healthcare Quality by the National Association for Healthcare Quality (NAHQ).
  • NAHQ provides the industry-standard framework for healthcare quality competencies that reduce variability of healthcare delivery, by offering a common vocabulary and toolset.
  • Further, the Certified Professional in Healthcare Quality is the only accredited certification in healthcare quality.
  • By becoming a Certified Professional in Healthcare Quality, he will further advance healthcare quality and safety initiatives for his clients by driving sustainability, improvement opportunities, and increasing patient safety—three critical factors impacting hospitals and health systems today.

SAINT LOUIS UNIVERSITY TEAMS UP WITH QUEST DIAGNOSTICS ON ACCELERATED BACHELOR OF SCIENCE IN MEDICAL LABORATORY SCIENCE

Retrieved on: 
Friday, October 28, 2022
Catholic (term), Infection, Blood, Diabetes, Certification, University, Glass, Quest Diagnostics, MLS, Society, Diagnosis, Cancer, Hematology, Hospital, Saint Louis University (Philippines), Gaps, Physician, Department, Saint Louis University, SLU, Program, Database, Patient, Student, Bureau of Labor Statistics, Education, Adult, Mississippi River, American Society for Clinical Pathology, COVID-19, Health, Medical laboratory scientist, Outline of health sciences, DGX, NYSE, Society of Glass Technology, ASCP, Treatment, Accreditation, Medical device, Medicine, Pharmaceutical industry, Society of Jesus, Quest

ST. LOUIS, Oct. 28, 2022  /PRNewswire/ -- A preeminent Jesuit research university and the world's leading provider of diagnostic information services are teaming up to fill a dire shortage of workers in a vital but little-known field.

Key Points: 
  • Saint Louis University and Quest Diagnostics (NYSE: DGX) are partnering to launch an accelerated bachelor's degree program in medical laboratory science.
  • The 16-month program will combine online academic courses with intensive hands-on learning and clinical experiences in Quest's Lenexa, Kansas laboratory.
  • "Medical laboratory scientists are the hidden heroes who help save lives every day," said Amanda Reed, Medical Laboratory Science Program director and assistant professor in the Department of Clinical Health Sciences at Saint Louis University's Doisy College of Health Sciences.
  • While most patients will never see a medical laboratory scientist, Reed said these professionals' impact on patient care is profound.

The Max Foundation Announces Multi-Stakeholder Collaboration to Improve Outcomes for People Living with Advanced Breast Cancer in Low-Resource Countries

Retrieved on: 
Thursday, October 27, 2022
American Society for Clinical Pathology, Growth, Goal, Marketing, Solution, ABC, Student, Research, Program, Society, Death, ASCP, Health, Infection, Health equity, Cancer, Heart, MAS, Novartis, Technology, Patient, Cepheid variable, CEO, Breast cancer, Diagnosis, Sustainability, Man, SVP, Partner, PACT, Association, Organization, Awareness, Woman, Hope, Palliative care, Access, Molecular biology, Pathology, Dignity, Geography, Partnership, Knowledge, Max, HR, European School, GM, Pharmaceutical industry, Birth control, Medical imaging, Hospital, Developing country, Humanitarianism

SEATTLE, Oct. 27, 2022 /PRNewswire-PRWeb/ -- The Max Foundation Announces Multi-Stakeholder Collaboration to Improve Outcomes for People Living with Advanced Breast Cancer in Low-Resource Countries

Key Points: 
  • Next year, The Max Foundation will expand this innovative partnership model to include treatment for advanced breast cancer.
  • "While there is great worldwide awareness of breast cancer today, the urgent needs of people living with advanced breast cancer in low-resource countries have been overlooked.
  • With the addition of breast cancer, starting in 2023, The Max Foundation will provide access to cancer treatments for 12 different diseases in over 70 low-resource countries.
  • We are excited to expand our collaboration with Max and all the partners in the Humanitarian PACT to improve outcomes for people living with advanced breast cancer in low-resource countries."

Torrance Memorial Medical Center first in nation to receive Leading Laboratories recognition from ASCP and The Joint Commission

Retrieved on: 
Tuesday, September 27, 2022
Magnet, Torrance Memorial Medical Center, Cedars-Sinai Medical Center, American Society for Clinical Pathology, U.S. News & World Report, Culture, Laboratory, Efficiency, Knowledge, News, Joint Commission, American Nurses Credentialing Center, Society, Growth, Health, ASCP, Review, Program, Patient, International Laboratory Accreditation Cooperation, Physician, CEO, Student, Pathology, U.S. News & World Report Best Hospitals Rankings, Leadership, Doctor of Philosophy, Overalls, Communication, Education, SCT, Healthcare, Pharmaceutical industry, Management, Hospital, Medicine, Harbor

CHICAGO, Sept. 27, 2022 /PRNewswire-PRWeb/ -- Torrance Memorial Medical Center today announced it is the first in the nation to receive the Leading Laboratories recognition from the American Society for Clinical Pathology (ASCP) and The Joint Commission. The two-year designation serves as proof of Torrance Memorial's commitment to laboratory excellence and to help improve patient outcomes.

Key Points: 
  • CHICAGO, Sept. 27, 2022 /PRNewswire-PRWeb/ -- Torrance Memorial Medical Center today announced it is the first in the nation to receive the Leading Laboratories recognition from the American Society for Clinical Pathology (ASCP) and The Joint Commission.
  • Torrance Memorial underwent a rigorous application process to receive the recognition, including a review of its outcomes, indicators, metrics and evidence.
  • This designation reflects the commitment to excellence by every member of the Torrance Memorial Pathology and Clinical Laboratory," said Keith Hobbs, executive vice president, Torrance Memorial Medical Center.
  • "We congratulate Torrance Memorial Medical Center on being the first in the nation to receive the Leading Laboratories recognition," said Heather Hurley, executive director, Laboratory Accreditation, The Joint Commission.